Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression

Nucleic Acids Research

Volumn 41, Issue 22, 2013, Pages

  Li, Yongsheng ^a   Xu, Juan ^a   Chen, Hong ^a   Bai, Jing ^a   Li, Shengli ^a   Zhao, Zheng ^a   Shao, Tingting ^a   Jiang, Tao ^b   Ren, Huan ^a   Kang, Chunsheng ^c   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CDK2 GENE; CELL CYCLE; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GLIOBLASTOMA; GLIOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TTK GENE; TUMOR GROWTH; WEE1 GENE;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84890391023     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1054     Document Type: Article

References (57)

1. Deorah, S., Lynch, C.F., Sibenaller, Z.A. and Ryken, T.C. (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg. Focus, 20, E1.
2. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U. et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl. J. Med., 352, 987-996.
3. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
4. Gregory, R.I. and Shiekhattar, R. (2005) MicroRNA biogenesis and cancer. Cancer Res., 65, 3509-3512.
5. Davis-Dusenbery, B.N. and Hata, A. (2010) MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways. Genes Cancer, 1, 1100-1114.
6. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
7. Ciafre, S.A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.G., Sabatino, G., Negrini, M., Maira, G., Croce, C.M. and Farace, M.G. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun., 334, 1351-1358.
8. Rao, S.A., Santosh, V. and Somasundaram, K. (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Modern Pathol., 23, 1404-1417.
9. Zhang, W., Zhang, J., Yan, W., You, G., Bao, Z., Li, S., Kang, C., Jiang, C., You, Y., Zhang, Y. et al. (2012) Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer, 119, 814-824.
10. Srinivasan, S., Patric, I.R. and Somasundaram, K. (2011) A tenmicroRNA expression signature predicts survival in glioblastoma. PloS One, 6, e17438.
11. Djuranovic, S., Nahvi, A. and Green, R. (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science, 336, 237-240.
12. Baek, D., Villen, J., Shin, C., Camargo, F.D., Gygi, S.P. and Bartel, D.P. (2008) The impact of microRNAs on protein output. Nature, 455, 64-71.
13. Hausser, J., Syed, A.P., Bilen, B. and Zavolan, M. (2013) Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res., 23, 604-615.
14. Fu, J., Tang, W., Du, P., Wang, G., Chen, W., Li, J., Zhu, Y., Gao, J. and Cui, L. (2012) Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst. Biol., 6, 68.
15. Naydenov, E., Tzekov, C., Minkin, K., Nachev, S., Romansky, K. and Bussarsky, V. (2011) Long-term survival with primary glioblastoma multiforme: a clinical study in bulgarian patients. Case Rep. Oncol., 4, 1-11.
16. Xu, J., Li, C.X., Lv, J.Y., Li, Y.S., Xiao, Y., Shao, T.T., Huo, X., Li, X., Zou, Y., Han, Q.L. et al. (2011) Prioritizing candidate disease miRNAs by topological features in the miRNA targetdysregulated network: case study of prostate cancer. Mol. Cancer Therap., 10, 1857-1866.
17. Peng, X., Li, Y., Walters, K.A., Rosenzweig, E.R., Lederer, S.L., Aicher, L.D., Proll, S. and Katze, M.G. (2009) Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics, 10, 373.
18. Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C.V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R. et al. (2013) Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell, 23, 186-199.
19. Kozomara, A. and Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res., 39, D152-D157.
20. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
21. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
22. Maragkakis, M., Reczko, M., Simossis, V.A., Alexiou, P., Papadopoulos, G.L., Dalamagas, T., Giannopoulos, G., Goumas, G., Koukis, E., Kourtis, K. et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res., 37, W273-W276.
23. Sethupathy, P., Megraw, M. and Hatzigeorgiou, A.G. (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods, 3, 881-886.
24. Ritchie, W., Flamant, S. and Rasko, J.E. (2009) Predicting microRNA targets and functions: traps for the unwary. Nat. Methods, 6, 397-398.
25. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser B, 57, 289-300.
26. Yu, S.L., Chen, H.Y., Chang, G.C., Chen, C.Y., Chen, H.W., Singh, S., Cheng, C.L., Yu, C.J., Lee, Y.C., Chen, H.S. et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
27. Simon, R., Radmacher, M.D., Dobbin, K. and McShane, L.M. (2003) Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl Cancer Inst., 95, 14-18.
28. Taylor, I.W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q. and Wrana, J.L. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol., 27, 199-204.
29. Batada, N.N., Reguly, T., Breitkreutz, A., Boucher, L., Breitkreutz, B.J., Hurst, L.D. and Tyers, M. (2006) Stratus not altocumulus: a new view of the yeast protein interaction network. PLoS Biol., 4, e317.
30. Agarwal, S., Deane, C.M., Porter, M.A. and Jones, N.S. (2010) Revisiting date and party hubs: novel approaches to role assignment in protein interaction networks. PLoS Comput. Biol., 6, e1000817.
31. Wang, J., Duncan, D., Shi, Z. and Zhang, B. (2013) WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res., 41, W77-W83.
32. Huang, J.C., Babak, T., Corson, T.W., Chua, G., Khan, S., Gallie, B.L., Hughes, T.R., Blencowe, B.J., Frey, B.J. and Morris, Q.D. (2007) Using expression profiling data to identify human microRNA targets. Nat. Methods, 4, 1045-1049.
33. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., Li, M., Wang, G. and Liu, Y. (2009) MiR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res., 37, D98-D104.
34. Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W. and Cui, Q. (2008) An analysis of human microRNA and disease associations. PloS One, 3, e3420.
35. Wypych, D. and Pomorski, P. (2013) Calcium signaling in glioma cells-the role of nucleotide receptors. Adv. Exp. Med. Biol., 986, 61-79.
36. Foster, S.S., De, S., Johnson, L.K., Petrini, J.H. and Stracker, T.H. (2012) Cell cycle-and DNA repair pathway-specific effects of apoptosis on tumor suppression. Proc. Natl Acad. Sci. USA, 109, 9953-9958.
37. Tian, Y., Wan, H. and Tan, G. (2012) Cell cycle-related kinase in carcinogenesis. Oncol. Lett., 4, 601-606.
38. Chen, L., Zhang, W., Yan, W., Han, L., Zhang, K., Shi, Z., Zhang, J., Wang, Y., Li, Y., Yu, S. et al. (2012) The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Carcinogenesis, 33, 2276-2282.
39. Moller, H.G., Rasmussen, A.P., Andersen, H.H., Johnsen, K.B., Henriksen, M. and Duroux, M. (2013) A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol. Neurobiol., 47, 131-144.
40. Hua, D., Mo, F., Ding, D., Li, L., Han, X., Zhao, N., Foltz, G., Lin, B., Lan, Q. and Huang, Q. (2012) A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing. Omics, 16, 690-699.
41. Ma, R., Zhang, G., Wang, H., Lv, H., Fang, F. and Kang, X. (2012) Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma. Oncol. Lett., 4, 1321-1324.
42. Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stuhler, K., Meyer, H.E. and Reifenberger, G. (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol., 20, 539-550.
43. Xin, C., Buhe, B., Hongting, L., Chuanmin, Y., Xiwei, H., Hong, Z., Lulu, H., Qian, D. and Renjie, W. (2013) MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteinerich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. FEBS J., 280, 855-866.
44. Vermeulen, K., Van Bockstaele, D.R. and Berneman, Z.N. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferat., 36, 131-149.
45. Mir, S.E., De Witt Hamer, P.C., Krawczyk, P.M., Balaj, L., Claes, A., Niers, J.M., Van Tilborg, A.A., Zwinderman, A.H., Geerts, D., Kaspers, G.J. et al. (2010) In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell, 18, 244-257.
46. Kim, S.Y. and Ferrell, J.E. Jr (2007) Substrate competition as a source of ultrasensitivity in the inactivation of Wee1. Cell, 128, 1133-1145.
47. Foti, C., Florean, C., Pezzutto, A., Roncaglia, P., Tomasella, A., Gustincich, S. and Brancolini, C. (2009) Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitinproteasome system. Mol. Cancer Therap., 8, 3140-3150.
48. Turcan, S., Rohle, D., Goenka, A., Walsh, L.A., Fang, F., Yilmaz, E., Campos, C., Fabius, A.W., Lu, C., Ward, P.S. et al. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature, 483, 479-483.
49. Rossetto, M., Ciccarino, P., Boisselier, B., Labussiere, M. and Sanson, M. (2011) Metabolism of glioma and IDH1/IDH2 mutations. Rev. Neurol., 167, 699-703.
50. Sonoda, Y., Kumabe, T., Nakamura, T., Saito, R., Kanamori, M., Yamashita, Y., Suzuki, H. and Tominaga, T. (2009) Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci., 100, 1996-1998.
51. Madhavan, S., Zenklusen, J.C., Kotliarov, Y., Sahni, H., Fine, H.A. and Buetow, K. (2009) Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res., 7, 157-167.
52. Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
53. Kim, T.M., Huang, W., Park, R., Park, P.J. and Johnson, M.D. (2011) A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res., 71, 3387-3399.
54. Li, R.Y., Chen, L.C., Zhang, H.Y., Du, W.Z., Feng, Y., Wang, H.B., Wen, J.Q., Liu, X., Li, X.F., Sun, Y. et al. (2013) MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma. CNS Neurosci. Ther., 19, 477-483.
55. Yan, W., Zhang, W., You, G., Zhang, J., Han, L., Bao, Z., Wang, Y., Liu, Y., Jiang, C., Kang, C. et al. (2012) Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol., 14, 1432-1440.
56. Hsu, S.D., Lin, F.M., Wu, W.Y., Liang, C., Huang, W.C., Chan, W.L., Tsai, W.T., Chen, G.Z., Lee, C.J., Chiu, C.M. et al. (2011) MiRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39, D163-D169.
57. Witkos, T.M., Koscianska, E. and Krzyzosiak, W.J. (2011) Practical aspects of microRNA target Prediction. Curr. Mol. Med., 11, 93-109.